(Q36332869)

13 August 2017

1 reference

title

Endothelins: pathophysiology and treatment implications in chronic heart failure (English)

1 reference

13 August 2017

0 references

chronic heart failure

1 reference

1

John R Teerlink

1 reference

13 August 2017

1 December 2005

1 reference

Current heart failure reports

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

4

1 reference

13 August 2017

191-197

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02696649

13 August 2017

0 references

cites work

Increased endothelin in experimental heart failure

1 reference

https://api.crossref.org/works/10.1007%2FBF02696649

Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02696649

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02696649

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02696649

Characterization of a coronary vasoconstrictor produced by cultured endothelial cells

21 January 2018

1 reference

12 December 2020

Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart

1 reference

12 December 2020

Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

1 reference

12 December 2020

Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study

1 reference

12 December 2020

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

1 reference

12 December 2020

Plasma endothelin in chronic heart failure

1 reference

12 December 2020

Contribution of endogenous generation of endothelin-1 to basal vascular tone

1 reference

12 December 2020

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

1 reference

12 December 2020

Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure

1 reference

12 December 2020

Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist

1 reference

12 December 2020

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

12 December 2020

Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators

1 reference

12 December 2020

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

1 reference

12 December 2020

Clinical experience with endothelin receptor antagonists in chronic heart failure

1 reference

12 December 2020

Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins

1 reference

12 December 2020

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.

1 reference

12 December 2020

Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure

1 reference

12 December 2020

Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction

1 reference

12 December 2020

Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure

1 reference

12 December 2020

Pathophysiology of endothelin in the cardiovascular system

1 reference

12 December 2020

Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat

1 reference

12 December 2020

Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)

1 reference

12 December 2020

Transcardiac extraction of circulating endothelin-1 across the failing heart

1 reference

12 December 2020

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

12 December 2020

Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling

1 reference

12 December 2020

Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.

1 reference

12 December 2020

Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist

1 reference

12 December 2020

Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs

1 reference

12 December 2020

Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?

1 reference

12 December 2020

Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology

1 reference

12 December 2020

Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure

1 reference

12 December 2020

Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.

1 reference

12 December 2020

Characterization of endothelin receptors mediating contraction of rabbit saphenous vein

1 reference

12 December 2020

Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.

1 reference

12 December 2020

Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction

1 reference

12 December 2020

Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure

1 reference

12 December 2020

Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?

1 reference

12 December 2020

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

1 reference

12 December 2020

Endothelin in human congestive heart failure

1 reference

12 December 2020

Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02696649

1 reference

13 August 2017

1 reference

PubMed ID

16332312